Naftin Gel
Product Images NDC 83107-023

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Naftin (NDC 83107-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Legacy Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Naftin 45a)

Label for Naftin (Naftifine Hydrochloride) Gel 2%, a topical prescription drug. The label states it is for topical use only and not for ophthalmic, oral, or intravaginal use. The package contains 45 grams and is manufactured for Legacy Pharma Inc., Georgetown, Grand Cayman. The label includes active and inactive ingredients, storage instructions, and a barcode.*

FDA Label Image

Image Description (Naftin 60a)

Label for Naftin (Naftifine Hydrochloride) Gel, 2% topical prescription drug. The label indicates a 60g package, states the product is for topical use only, and lists active and inactive ingredients. It includes storage instructions and manufacturer information for Legacy Pharma USA Inc. A barcode and NDC 83107-02360 are also present.*

FDA Label Image

Image Description (Naftin 01a)

Chemical structure of Naftifine Hydrochloride, showing the molecular arrangement including aromatic rings, double bonds, and the hydrochloride component, as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.